2022.07.11
CCH and MIRDC co-hosted the “ Innovative Technology on Cancer Precision Screening” Workshop
On July 8th, Changhua Christian Hospital (CCH) and the Metal Industries Research & Development Centre (MIRDC) co-organized the “Innovative Technology on Cancer Precision Screening” workshop, which was sponsored by the Industrial Bureau of the Ministry (IDB) of Economic Affairs. At the beginning of the seminar, Dr. Guan-Min Lai, Director of Hematology & Oncology Department, CCH, shared the experiences of CCH adopting innovative precision medicine in cancer, followed by five excellent precision medicine companies presenting the feature of their products. The five cancer precision screening device companies, including AmCad BioMed Corporation, VITAE Biomedical Co., Ltd., Good Future BioMed. Inc., JelloX Biotech Inc., and Molsentech Co., Ltd. Through the presentation and on-site demonstration, over 70 participants interacted and exchanged experiences for each other.